Medication prescribing errors pertaining to cardiovascular/antidiabetic medications: a prescription audit in primary care
- 25 January 2011
- journal article
- Published by Wiley in Fundamental & Clinical Pharmacology
- Vol. 26 (3), 410-417
- https://doi.org/10.1111/j.1472-8206.2011.00924.x
Abstract
This study was carried out to identify the medication prescribing errors (MPEs) pertaining to cardiovascular/antidiabetic medications in prescriptions issued to hypertensive and diabetic hypertensive patients. A retrospective, nationwide audit of prescriptions (n = 2773) issued by primary care physicians (n = 194) of 20 health centres in Bahrain was carried out. Approximately one-quarter of prescriptions ordered by two-thirds of primary care physicians had errors. No significant differences with respect to overall errors were evident in prescriptions ordered by the family physicians and general practitioners. The most common error (in 8.0% of prescriptions) was prescribing β-blockers or diuretics (thiazide) or their combinations to patients on lipid-lowering drugs. Prescribing multiple antihypertensives, often with a similar mechanism, accounted for 2.2% errors: approximately half of these (1.45%) were two angiotensin-converting enzyme inhibitors (ACEIs) co-prescribed and/or ACEIs plus angiotensin-II receptor blockers. In 0.7% of prescriptions, β-blockers were ordered to patients on salbutamol treatment. High-dose metformin (3 g/day) was prescribed to approximately 4% diabetic hypertensives; of these, many were elderly patients. Prescribing high-dose glibenclamide (median dose 15 mg) to the elderly accounted for 3.6% of the overall errors. Polypharmacy, such as aspirin along with an immediate-release dipyridamole, was prescribed occasionally (0.25%), particularly by the general practitioners (P = 0.0139). MPEs are common in primary care, in Bahrain. Some of these prescribing errors have the potential to harm patients. Effective measures to detect and prevent such errors are needed to improve the quality of health care. Standard treatment guidelines and educational interventions are important strategies to achieve these goals.Keywords
This publication has 38 references indexed in Scilit:
- Dual Blockade of the Renin-Angiotensin System for Cardiorenal Protection: An UpdateAmerican Journal of Kidney Diseases, 2009
- Aspirin Plus Dipyridamole Versus Aspirin for Prevention of Vascular Events After Stroke or TIAStroke, 2008
- 2007 Guidelines for the Management of Arterial HypertensionJournal of Hypertension, 2007
- Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trialThe Lancet, 2006
- Clarification of Terminology in Medication ErrorsDrug Safety, 2006
- What is a prescribing error?Quality in health care : QHC, 2000
- Long-term Effects on Sexual Function of Five Antihypertensive Drugs and Nutritional Hygienic Treatment in Hypertensive Men and WomenHypertension, 1997
- Comparison of Nifedipine Alone and With Diltiazem or Verapamil in HypertensionHypertension, 1996
- Different effects of glyburide and glipizide on insulin secretion and hepatic glucose production in normal and NIDDM subjectsDiabetes, 1987
- "AICLA" controlled trial of aspirin and dipyridamole in the secondary prevention of athero-thrombotic cerebral ischemia.Stroke, 1983